These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1120 related articles for article (PubMed ID: 27934854)

  • 21. Lifestyle factors and multiple sclerosis: A population-based incident case-control study.
    Abdollahpour I; Nedjat S; Mansournia MA; Sahraian MA; van der Mei I
    Mult Scler Relat Disord; 2018 May; 22():128-133. PubMed ID: 29677591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric Multiple Sclerosis: Genes, Environment, and a Comprehensive Therapeutic Approach.
    Cappa R; Theroux L; Brenton JN
    Pediatr Neurol; 2017 Oct; 75():17-28. PubMed ID: 28843454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.
    Ascherio A; Munger KL
    Semin Neurol; 2016 Apr; 36(2):103-14. PubMed ID: 27116717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental factors in multiple sclerosis.
    Pantazou V; Schluep M; Du Pasquier R
    Presse Med; 2015 Apr; 44(4 Pt 2):e113-20. PubMed ID: 25744944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
    Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D
    Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis.
    Jelinek GA; Marck CH; Weiland TJ; Pereira N; van der Meer DM; Hadgkiss EJ
    BMC Neurol; 2015 Aug; 15():132. PubMed ID: 26243188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental risk factors in multiple sclerosis.
    Pugliatti M; Harbo HF; Holmøy T; Kampman MT; Myhr KM; Riise T; Wolfson C
    Acta Neurol Scand Suppl; 2008; 188():34-40. PubMed ID: 18439219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis: risk factors and their interactions.
    Disanto G; Morahan JM; Ramagopalan SV
    CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):545-55. PubMed ID: 22583442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors.
    Ascherio A; Munger KL
    Ann Neurol; 2007 Jun; 61(6):504-13. PubMed ID: 17492755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Western lifestyle and immunopathology of multiple sclerosis.
    Matveeva O; Bogie JFJ; Hendriks JJA; Linker RA; Haghikia A; Kleinewietfeld M
    Ann N Y Acad Sci; 2018 Apr; 1417(1):71-86. PubMed ID: 29377214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental triggers of multiple sclerosis.
    Kakalacheva K; Lünemann JD
    FEBS Lett; 2011 Dec; 585(23):3724-9. PubMed ID: 21486562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sociodemographic, environmental and lifestyle risk factors for multiple sclerosis development in the Western region of Saudi Arabia. A matched case control study.
    Halawani AT; Zeidan ZA; Kareem AM; Alharthi AA; Almalki HA
    Saudi Med J; 2018 Aug; 39(8):808-814. PubMed ID: 30106419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The causal cascade to multiple sclerosis: a model for MS pathogenesis.
    Goodin DS
    PLoS One; 2009; 4(2):e4565. PubMed ID: 19242548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifiable environmental factors in multiple sclerosis.
    Fragoso YD
    Arq Neuropsiquiatr; 2014 Nov; 72(11):889-94. PubMed ID: 25410457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis.
    Taylor KL; Hadgkiss EJ; Jelinek GA; Weiland TJ; Pereira NG; Marck CH; van der Meer DM
    BMC Psychiatry; 2014 Dec; 14():327. PubMed ID: 25467385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Environmental and genetic factors in pediatric inflammatory demyelinating diseases.
    Waubant E; Ponsonby AL; Pugliatti M; Hanwell H; Mowry EM; Hintzen RQ
    Neurology; 2016 Aug; 87(9 Suppl 2):S20-7. PubMed ID: 27572857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of multiple sclerosis: from risk factors to prevention.
    Ascherio A; Munger K
    Semin Neurol; 2008 Feb; 28(1):17-28. PubMed ID: 18256984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the Nature of Evidence and 'Proving' Causality: Smoking and Lung Cancer vs. Sun Exposure, Vitamin D and Multiple Sclerosis.
    Lucas RM; Rodney Harris RM
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30103527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway.
    Kampman MT; Brustad M
    Neuroepidemiology; 2008; 30(3):140-6. PubMed ID: 18382112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
    Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J
    J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.